Nora T. Jaskowiak to Neoplasm Staging
This is a "connection" page, showing publications Nora T. Jaskowiak has written about Neoplasm Staging.
Connection Strength
0.292
-
The Prognostic Value of the AJCC 8th Edition Staging System for Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg Oncol. 2020 Feb; 27(2):352-358.
Score: 0.121
-
Impact of post-diagnosis weight change on survival outcomes in Black and White breast cancer patients. Breast Cancer Res. 2021 02 04; 23(1):18.
Score: 0.033
-
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial. JAMA Oncol. 2020 05 01; 6(5):676-684.
Score: 0.032
-
Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers. Clin Cancer Res. 2019 03 15; 25(6):1786-1794.
Score: 0.028
-
Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes. Ann Surg Oncol. 2015 Dec; 22(13):4295-304.
Score: 0.022
-
Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998-2009. Ann Surg Oncol. 2014 Apr; 21(4):1222-30.
Score: 0.020
-
Operative risks associated with contralateral prophylactic mastectomy: a single institution experience. Ann Surg Oncol. 2013 Dec; 20(13):4113-20.
Score: 0.020
-
Breast cancers not detected at MRI: review of false-negative lesions. AJR Am J Roentgenol. 2010 Jun; 194(6):1674-9.
Score: 0.016